Analyst Price Targets — MLSS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 17, 2026 1:44 pm | — | Morgan Stanley | $1.00 | $0.47 | StreetInsider | Benchmark Reiterates Speculative Buy Rating on Milestone Scientific (MLSS) |
| April 4, 2022 3:32 pm | Anthony Vendetti | Maxim Group | $4.00 | $1.53 | Benzinga | Here's Why Maxim Reduced Price Target On Milestone Scientific |
Latest News for MLSS
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
Medical Segment Revenue Grows 231% Year-Over-Year Enters Strategic Distribution Agreement to Expand CompuFlo® Access Across VA and Department of Defense Health Systems Reaffirms 2026 Outlook for Double-Digit Revenue Growth, Including Significant Growth in CompuFlo® Sales ROSELAND, N.J., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments…
ROSELAND, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, August 14, 2026, to discuss the company's financial results for the second quarter ended June 30, 2026, as well as the company's…
Partnership Expands Commercial Reach Across VA, Department of Defense and Other Federal Healthcare Systems Partnership Expands Commercial Reach Across VA, Department of Defense and Other Federal Healthcare Systems
AI-powered Initiative Aims to Enhance Customer Engagement, Accelerate Commercial Execution and Support Long-Term Growth
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MLSS.
U.S. House Trading
No House trades found for MLSS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.